According to Aerovate Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.17. In 2022 the company made an earnings per share (EPS) of -$3.38 an increase over its 2021 EPS that were of -$39.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.90 | 15.33% |
2022 | -$3.38 | -91.4% |
2021 | -$39.33 | -29.07% |
2020 | -$55.45 |